Ignite Creation Date:
2024-05-06 @ 8:08 PM
Last Modification Date:
2024-10-26 @ 3:21 PM
Study NCT ID:
NCT06262399
Status:
ENROLLING_BY_INVITATION
Last Update Posted:
2024-05-24
First Post:
2024-01-12
Brief Title:
Long-Term Follow-Up LTFU of Subjects Treated with NTLA 2002
Sponsor:
Intellia Therapeutics
Organization:
Intellia Therapeutics
Study Overview
Official Title:
Long-Term Follow-Up of Subjects Treated with NTLA 2002
Status:
ENROLLING_BY_INVITATION
Status Verified Date:
2024-01
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This is a follow-up study of subjects who received NTLA-2002 in a previous clinical trial as an observational evaluation of the long-term effects of the investigational therapy
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None
Secondary IDs
| Secondary ID | Type | Domain | Link |
|---|---|---|---|
| 2022-003778-22 | EUDRACT_NUMBER | None | None |